Welcome to the Dominantly Inherited Alzheimer Network (DIAN). DIAN is an international research partnership of leading scientists determined to understand a rare form of Alzheimer’s disease that is caused by a gene mutation. Understanding of this form of Alzheimer's disease may provide clues to decoding other dementias and developing dementia treatments. 

Funded by a multiple-year research grant from the National Institute on Aging, DIAN currently involves outstanding research institutions in the United States, Australia, Europe, Asia and South America. Randall Bateman, M.D., Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine in St. Louis, is the project’s principal investigator. 

DIAN is currently enrolling study participants who are biological adult children of a parent with a mutated gene known to cause dominantly inherited Alzheimer’s disease. Such individuals may or may not carry the gene themselves and may or may not have disease symptoms (click here for information about genetic testing).

To register for DIAN drug trials or DIAN, visit www.dian-exr.org. To view a brochure about the DIAN drug trials, click HERE.